Butterfly Network, Inc. Class A

Stage 2 · Advancing · week 26

As of Oct 22, 2026, Butterfly Network is in Stage 2, the uptrend phase, now in week 26 (since Apr 20, 2026). It closed at $6.81, 31.4% below its 52-week high and above its 200-day average, which is rising.

Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. More about the company

$6.81

-4.08% today

$1.8B · Small cap

Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 35 in Medical Devices · #1 of 272 in Health Care

Is BFLY early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 20w

S4 14w

S2 29w

S4 22w

S2 18w

S2 27w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S1 1w → S4 20w → S1 4w → S4 3w → S1 5w → S4 14w → S1 2w → S2 2w → S1 3w → S2 29w → S3 7w → S4 22w → S1 7w → S2 18w → S3 3w → S2 27w current

Total tracked: 165 weeks across 16 stage runs.

BFLY among Medical Devices3rd of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%

vs 52W High

-31.4%

$1.97 lo$9.93 hi

31.4% below 52W high, far from high

How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.

Stage Maturity

Week 26

1w13w26w

Week 26, proven structure

How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.

vs 200 DMA

14.2%

200 DMA: $5.96 · rising

Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.

Rel Volume

1.08x

vs 50-day avg

Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-26.0%

+3.5%

+32.2%

YTD

+81.6%

+202.7%

Scan Membership

Breakout Watch

Latest: 2024-08-29

3 appearances in last 60 days. First seen: 2022-09-07.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S2

Wk 26 · Vol 1.08x

2026-10-21S2

Wk 26 · Vol 0.97x

2026-10-20S2

Wk 26 · Vol 0.66x

2026-10-19S2

Wk 26 · Vol 0.54x

2026-10-16S2

Wk 26 · Vol 0.86x

2026-10-15S2

Wk 25 · Vol 0.77x

2026-10-14S2

Wk 25 · Vol 0.75x

2026-10-13S2

Wk 25 · Vol 0.83x

2026-10-12S2

Wk 25 · Vol 0.67x

2026-10-09S2

Wk 25 · Vol 0.67x

2026-10-08S2

Wk 24 · Vol 1.18x

2026-10-07S2

Wk 24 · Vol 1.29x

Moving averages & range

50 DMA

$8.30

200 DMA

$5.96

52W High

$9.93

52W Low

$1.97

5D Low

$6.81

Resistance levels (recent highs)

20d High

$9.39

60d High

$9.93

120d High

$9.93

250d High

$9.93

Next resistance

+37.9%

to 20d High

ROE

-35.5%

Profit margin -66.7%

Dividend Yield

0.00%

P/B 9.5

Butterfly Network: quick answers

What stage is Butterfly Network in?

As of Oct 22, 2026, Butterfly Network (BFLY) is in Stage 2, the uptrend phase. It entered Stage 2 on Apr 20, 2026 and is in week 26. What the four stages mean

Is Butterfly Network in an uptrend?

Yes. Butterfly Network is in a Stage 2 uptrend. It trades 14.2% above its 200-day average, which is rising.

How far is Butterfly Network from its 52-week high?

Butterfly Network closed at $6.81 on Oct 22, 2026, 31.4% below its 52-week high of $9.93. Its 52-week low is $1.97.

How has Butterfly Network performed over the past year?

As of Oct 22, 2026, Butterfly Network is up 202.7% over the past year and up 81.6% so far in 2026.

Which sector and industry is Butterfly Network in?

Butterfly Network is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. The company offers Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging on a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; Butterfly Move, merging the mobility of a handheld with the stability of a full cart system; and iQ+ Bladder, a specialty product for bladder scanning market. It also provides Compass AI which offers one system to connect every device, workflow, and department; ScanLab, an AI-powered educational platform that provides written walkthroughs and reference imagery to guide real-time educational scanning; and Butterfly iQ+/iQ3 Vet, a third generation handheld ultrasound system. It sells and markets its products through a direct sales force, distributors, and e-commerce channels. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.